The overnight surge in Apple Inc.’s share price made the tech giant the first to hit the US$1 trillion market cap mark and has fired up our tech sector but the real action this reporting season could be outside IT. Nonetheless, the excitement on the NASDAQ helped lift the S&P/ASX 200 (Index:^AXJO) (ASX:XJO) index by 0.1% this morning with our local tech stars Appen Ltd (ASX: APX), Xero Limited (ASX: XRO) and WiseTech Global Ltd (ASX: WTC) leading the charge forward – just don’t expect them to help take the top 200 stock benchmark to fresh 10-year highs. Our market…
The overnight surge in Apple Inc.’s share price made the tech giant the first to hit the US$1 trillion market cap mark and has fired up our tech sector but the real action this reporting season could be outside IT.
Nonetheless, the excitement on the NASDAQ helped lift the S&P/ASX 200 (Index:^AXJO) (ASX:XJO) index by 0.1% this morning with our local tech stars Appen Ltd (ASX: APX), Xero Limited (ASX: XRO) and WiseTech Global Ltd (ASX: WTC) leading the charge forward – just don’t expect them to help take the top 200 stock benchmark to fresh 10-year highs.
Our market is likely to stay rangebound as investors sit on their hands to await the opening of the reporting season floodgates. The vast majority of companies will only unveil their profit results in the second half of this month.
This will give investors time to chew on Morgan’s latest conviction buy calls for the reporting season with the broker adding three new stocks to its “must-buy” list – and none of them in the IT sector.
The first is copper miner OZ Minerals Limited (ASX: OZL), which could seem to be a contrarian call given the sharp fall in the price of the red metal over the past few days on fears of the escalating trade tension between China and the US.
It’s base metals (like copper) that will be hit harder than the bulks (like iron ore) in any trade war but that shouldn’t take the shine off OZ Minerals.
“OZL enjoys robust cashflows from an established production base in copper, which has among the best outlooks in the commodities suite, driven by electrification of the developing world,” said Morgans.
“OZL’s counter-cyclical growth strategy will be rewarded as the Carrapateena development project is gradually de-risked in the coming 1-2 years, and could justify valuations closer to $12.50ps [per share] upon successful commissioning.”
The second stock the broker is recommending is overseas toll-road operator Atlas Arteria Group (ASX: ALX). This is despite the fact that infrastructure stocks, including Transurban Group (ASX: TCL) and Sydney Airport Holdings Pty Ltd (ASX: SYD), have been struggling due to rising global bond yields, which makes the sector look less appealing.
But Morgans believes the stock is cheap and the expected growth in Atlas Arteria’s dividend distributions over the next few years will more than offset the higher bond yields. Its distributions will be further bolstered by good cost control, a big drop in debt servicing and legislated tax cuts.
The third stock on the list is Volpara Health Technologies Ltd (ASX: VHT), which is working on a better way to detect breast cancer early.
“Volpara’s market share of breast screening in the US is currently 3.7% with a pathway to grow to 9% in FY19,” said the broker.
There’s another med-tech stock that investors should put on their radar, according to the experts at the Motley Fool.
This stock has enjoyed a good run but there’s plenty of growth left in the tank. Click on the free link below to find out what this stock is.
The ASX small cap up 285% with no sign of stopping...
One Australian company has developed a state of the art device that's revolutionizing hospitals all over the world. Even better, this device is so profitable that the company rakes in 90% margins. That's a lot of cash. So no wonder the stock's up 285% since 2008 – with no signs of stopping...
To discover the name and code, simply click the link below. You'll discover our expert's #1 medical technology pick... and you can decide for yourself whether to get invested today.
Click here to claim your free report.
Motley Fool contributor Brendon Lau has no position in any of the stocks mentioned. The Motley Fool Australia owns shares of and has recommended Sydney Airport Holdings Limited, Transurban Group, and VOLPARA FPO NZ. The Motley Fool Australia owns shares of Appen Ltd, WiseTech Global, and Xero. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.